S Kusaka, C Shima, K Wada, H Arahori, H … - British Medical Journal, 2008 - bjo.bmj.com Methods: A retrospective chart review was conducted of 23 consecutive eyes
(stage 3, three eyes; 4A, 18 eyes; 4B, two eyes) of 14 patients with vascularly
active ROP considered at high risk for progression or development of ... Cited by 10 - Related articles - All 5 versions
L Kong, HA Mintz-Hittner, RL Penland, FL … - Archives of Ophthalmology, 2008 - archopht.highwire.org Overexpression of vascular endothelial growth factor (VEGF) appears important in
the pathogenesis of retinopathy of prematurity (ROP). Bevacizumab (Avastin;
Genentech, Inc, South San Francisco, California) is a recombinant humanized ... Cited by 10 - Related articles - All 3 versions
S Honda, H Hirabayashi, Y Tsukahara, A Negi - Graefe's Archive for Clinical and Experimental …, 2008 - Springer Abstract Background Despite the recent reports describing the benefits of the
intravitreal injection of bevacizumab (IVB) to treat ocular neovascular
disorders, including retinopathy of prematurity (ROP), the possible adverse ... Cited by 13 - Related articles - BL Direct - All 4 versions
HA MINTZ-HITTNER, RR KUFFEL JR - Retina, 2008 - journals.lww.com From the *Department of Ophthalmology and Visual Science, University of Texas
Health Science Center - Houston Medical School, Houston, Texas; and †Retina
Specialists, PA, Corpus Christi, Texas. Supported by NEI Core Grant ... Cited by 20 - Related articles - BL Direct - All 4 versions
EJ Chung, JH Kim, HS Ahn, HJ Koh - Graefe's Archive for Clinical and Experimental …, 2007 - Springer Abstract Background This report describes the use of combined laser
photocoagulation and intravitreal bevacizumab administra- tion for aggressive
zone I retinopathy of prematurity (ROP). Methods A male patient, born at 25 ... Cited by 16 - Related articles - BL Direct - All 4 versions
GA LALWANI, AM BERROCAL, TG MURRAY, M … - Retina, 2008 - journals.lww.com GEETA A. LALWANI, MD, AUDINA M. BERROCAL, MD, TIMOTHY G. MURRAY, MD, MBA, MARIA
BUCH, MD, SCOTT CARDONE, MD, DITTE HESS, CRA, ROSE A. JOHNSON, RN, CARMEN A.
PULIAFITO, MD, MBA ... Purpose: To report the short term anatomic ... Cited by 5 - Related articles - BL Direct - All 2 versions
C Pieh, H Agostini, C Buschbeck, M Krüger, J … - British Journal of Ophthalmology, 2008 - bjo.bmj.com Methods: Blood samples of 63 preterm infants born at a postmenstrual age (PMA)
of 23–32 weeks were obtained between 5 days and 15 weeks after birth. 42
infants had no ROP, two had stage 1, nine stage 2 and 10 stage 3. Of these, ... Cited by 6 - Related articles - BL Direct - All 4 versions
A Travassos, S Teixeira, P Ferreira, I … - Ophthalmic surgery, lasers & imaging: the official … - ncbi.nlm.nih.gov 1: Ophthalmic Surg Lasers Imaging. 2007 May-Jun;38(3):233-7. Intravitreal
bevacizumab in aggressive posterior retinopathy of prematurity. ... Cited by 19 - Related articles - BL Direct - All 3 versions
… , ML HERNANDEZ-ROJAS, N Salazar-Teran … - Retina, 2008 - journals.lww.com HUGO QUIROZ-MERCADO, MD,* MARIA A. MARTINEZ-CASTELLANOS, MD,* MYRIAM L.
HERNANDEZ-ROJAS, MD,* NELIDA SALAZAR-TERAN, MD,* ROBINSON VERNON PAUL CHAN,
MD† ... Purpose: To evaluate the role of antiangiogenic therapy with ... Cited by 4 - Related articles - BL Direct - All 3 versions
